The taxane-based chemotherapy triplet is superior to the doublet in one to nine node-positive but not node-negative triple-negative breast cancer: results from a retrospective analysis

Background: Taxane-based regimens that are frequently used in adjuvant chemotherapy in early triple-negative breast cancer (TNBC) include a three-drug regimen (TAC and AC-T) and a two-drug regimen (TA and TC). Whether pathological lymph node stage guides taxane-based de-escalating chemotherapies in...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Sanxing, Shi, Yonggang, Lu, Shuo, He, Yujie, Jin, Guangyi, Zhang, Suzhi, Li, Xingya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545687/
https://www.ncbi.nlm.nih.gov/pubmed/33046986
http://dx.doi.org/10.7150/jca.44768

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545687/
https://www.ncbi.nlm.nih.gov/pubmed/33046986
http://dx.doi.org/10.7150/jca.44768

Ejemplares similares